Flagellate dermatitis

• (2022): Constantinou A+, Skin Health Dis 2(1), e92 (54 cases) [REVIEW]

Hyperkeratosis

• (2020): Vastarella M+, Drug Saf Jan, Epub ahead of print [REVIEW]

Hyperpigmentation

• (2024): Shan J+, Arch Dermatol Res 316(6), 215 [REVIEW]

Hypersensitivity

• (2023): Galateanu B+, Int J Mol Sci 24(4), 3886 [REVIEW]

Leg ulceration

• (2025): Rousselot M+, J Wound Care 34(3), 250-254 (45 cases)

Photosensitivity

• (2024): Fattore D+, Ital J Dermatol Venerol Jun, Online ahead of print [REVIEW]

Toxic erythema of chemotherapy (TEC)

• (2023): Nguyen CV+, JAMA Dermatol 159(2), 219-222 (6 cases)
• (2021): Ríos-Viñuela E+, Acta Derm Venereol 101(4), adv00429 (45 cases) (localized epidermal necrolysis at the infusion site classified as "localized injection-site TEC")

Alopecia / hair loss

• (2024): Aoyama Y+, Breast Cancer 31(2), 234-242 (Chemotherapy-Induced Alopecia Distress Scale )
• (2024): Kraehenbuehl L+, Support Care Cancer 32(6), 369 (Chemotherapy-Induced Alopecia Distress Scale )
• (2022): Hrin ML+, J Am Acad Dermatol 86(6), 1434-1435 [REVIEW]
• (2018): Dunnill CJ+, Oncologist 23(1), 84-96
• (2011): Miteva M+, Am J Dermatopathol 33(4), 345-50 (10 cases)

Burning Mouth Syndrome / glossodynia / glossalgia / glossopyrosis (also includes stomatodynia / oral dysesthesia / stomatopyrosis)

• (2021): Hino S+, Ann Maxillofac Surg 11(1), 86-90 (15 cases)

Stomatitis (oral mucositis)

• (2023): Śledzińska A+, Cancer Invest Mar, Online ahead of print [REVIEW]

Ulcerative stomatitis

• (2021): Satheeshkumar PS+, Int J Med Inform Aug, Online ahead of print [REVIEW]

Atrial fibrillation

• (2024): Tamargo J+, Pharmacol Res Jan, Online ahead of print [REVIEW]

Bradycardia / sinus bradycardia

• (2022): Tamargo J+, Drug Saf Jan, Online ahead of print [REVIEW]

Capillary leak syndrome

• (2022): Izzedine H+, Kidney Int Rep 7(5), 945-953 [REVIEW]

Cardiomyopathy

• (2025): Fazzini L+, J Clin Med 14(4), 1286 [REVIEW] (pharmacogenomics)

Cardiotoxicity

• (2025): Chan SHY+, Cancers (Basel) 17(2), 311 (pharmacovigilance / pharmacoepidemiology)
• (2024): Jaiswal V+, Medicina (Kaunas) 60(4), 580 [REVIEW] (cardioprotective benefits associated with concomitant statin therapy)
• (2023): Qu Y+, Drug Discov Today Sep, Online ahead of print (association)

Anosmia (smell loss) / smell disorder

• (2023): Debbaneh P+, Auris Nasus Larynx Jan, Online ahead of print (association)

Dysgeusia (taste perversion)

• (2021): Hino S+, Ann Maxillofac Surg 11(1), 86-90 (12 cases)

Leukoencephalopathy / posterior reversible encephalopathy syndrome (PRES)

• (2024): Lei CL+, Expert Opin Drug Saf Mar, Online ahead of print (pharmacovigilance)

Peripheral neuropathy

• (2025): Belsky JA+, Support Care Cancer 33(4), 350 [REVIEW]
• (2025): Jiang J+, Cancer Lett Mar, Online ahead of print [REVIEW]
• (2025): Yanbing L+, World J Surg Oncol 23(1), 77 [REVIEW]
• (2024): Tao Z+, Cancer Lett Dec, Online ahead of print [REVIEW]
• (2022): Tay N+, Front Mol Biosci Oct (e-Collection) [REVIEW]
• (2021): Hino S+, Ann Maxillofac Surg 11(1), 86-90 (13 cases)
• (2021): Hung HW+, Int J Environ Res Public Health 18(11), 5677
• (2021): Inoue M+, Sci Rep 11(1), 11324 [REVIEW]
• (2021): Li T+, Neurol Sci 42(10), 4109-4121 [REVIEW]
• (2021): Selvy M+, Support Care Cancer 29(7), 4033-4043
• (2011): Balayssac D+, Expert Opin Drug Saf 10(3), 407-17 [REVIEW]

Hypothyroidism

• (2022): Deligiorgi MV+, Expert Rev Clin Pharmacol Jun, Online ahead of print [REVIEW]

Diarrhea

• (2022): Okunaka M+, Int J Mol Sci 23(20), 12407

Esophagitis

• (2022): Abdi S+, Gastroenterol Hepatol Bed Bench 15(3), 219-224 [REVIEW]

Gastrointestinal adverse reaction

• (2022): Akbarali HI+, Adv Cancer Res 155, 131-166 [REVIEW]
• (2021): Kawasumi K+, Mol Clin Oncol 14(1), 12

Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)

• (2025): Chodup P+, Liver Int 45(2), e70002 [REVIEW]
• (2022): Sanguanboonyaphong P+, Asian Pac J Cancer Prev 23(1), 93-100
• (2021): Kong X+, Br J Clin Pharmacol May, Online ahead of print [REVIEW]

Nausea

• (2022): Sanguanboonyaphong P+, Asian Pac J Cancer Prev 23(1), 93-100

Neutropenic enterocolitis

• (2024): Amanati A+, J Oncol Pharm Pract Mar, Online ahead of print (pharmacovigilance)

Pneumatosis intestinalis / pneumatosis cystoides intestinalis

• (2022): Gazzaniga G+, Cancers (Basel) 14(7), 1666 [REVIEW]

Vomiting

• (2022): Sanguanboonyaphong P+, Asian Pac J Cancer Prev 23(1), 93-100

Gonadotoxicity

• (2024): Gentile G+, Cancer Treat Rev Jul, Online ahead of print [REVIEW]

Ovarian injury /ovarian damage

• (2024): Zha Y+, Zhejiang Da Xue Xue Bao Yi Xue Ban May, Online ahead of print [REVIEW]
• (2011): Hancke K+, Support Care Cancer 19(12), 1909-19 [REVIEW]
• (2001): Blumenfeld Z, J Soc Gynecol Investig 8(1 Suppl Proceedings), S60-4
• (1996): Bines J+, J Clin Oncol 14(5), 1718-29
• (1996): Blumenfeld Z+, Hum Reprod 11(8), 1620-6

Ovarian injury /ovarian damage

• (2024): Tanaka Y+, Curr Oncol Rep Nov, Online ahead of print [REVIEW]
• (2023): Bhardwaj JK+, J Biochem Mol Toxicol 37(7), e23371, Online ahead of print [REVIEW]

Anemia

• (2022): Sanguanboonyaphong P+, Asian Pac J Cancer Prev 23(1), 93-100

Neutropenia (neutrophils decreased)

• (2023): Mohanlal R+, Cancer Invest Mar, Online ahead of print [REVIEW]
• (2022): Sanguanboonyaphong P+, Asian Pac J Cancer Prev 23(1), 93-100

Thrombocytopenia / platelets decreased

• (2023): Zhou S+, Sci Rep 13(1), 3185
• (2022): Sanguanboonyaphong P+, Asian Pac J Cancer Prev 23(1), 93-100

Corneal neuropathic changes

• (2021): Chiang JCB+, Ocul Surf 21, 221-237 [REVIEW]

Ocular adverse effect

• (2022): Sakellakis M+, Cureus 14(7), e27266 [REVIEW]

Nephrotoxicity / kidney injury / acute kidney injury (AKI) / drug-induced kidney injury

• (2024): Connor S+, Drug Discov Today Mar, Online ahead of print [REVIEW]
• (2024): Yoon SY+, Sci Rep Jul (e-Collection) (pharmacovigilance / pharmacoepidemiology)
• (2022): Rey A+, Fundam Clin Pharmacol Jan, Online ahead of print

Interstitial lung disease / interstitial pneumonitis / interstitial pneumonia (cryptogenic organizing pneumonia) / drug-induced interstitial lung disease

• (2025): Hwang IH+, Expert Opin Drug Saf Feb, Online ahead of print [REVIEW] (pharmacovigilance / pharmacoepidemiology)
• (2024): Jiang T+, Ther Adv Drug Saf Jan (e-Collection) (pharmacovigilance)
• (2024): Ma Z+, Expert Opin Drug Saf Feb, Online ahead of print [REVIEW]
• (2024): Oishi K+, Respir Med, 107924
• (2023): Dai HP+, Curr Med Sci 43(1), 1-12 [REVIEW]
• (2022): Zhonghua Zhong Liu Za Zhi (Chinese) 44(7), 693-702 [REVIEW]
• (2022): Conte P+, ESMO Open 7(2), 100404
• (2022): Miyagahara T+, Asia Pac J Clin Oncol Dec, Online ahead of print6%

Pneumonitis

• (2024): Oishi K+, Respir Med Dec, Online ahead of print (interstitial lung abnormalities and other associated risk factors)

Pulmonary fibrosis

• (2024): McCall KL+, Pharmacoepidemiol Drug Saf 33(5), e5797 (association) (pharmacovigilance / pharmacoepidemiology)

Pulmonary toxicity

• (2025): Belluzzi L+, Breast Cancer (Dove Med Press) 17, 53-66 [REVIEW]

Adverse effects / adverse reactions

• (2024): Manzoor R+, J Ayub Med Coll Abbottabad 36(4), 816-820 (59 cases)
• (2024): Yan H+, Front Pharmacol Feb (e-Collection) [REVIEW]
• (2023): Longo V+, Thorac Cancer Mar, Online ahead of print [REVIEW]
• (2022): Yan YD+, EClinicalMedicine Aug (e-Collection) [REVIEW]
• (2021): Kawasumi K+, Mol Clin Oncol 14(1), 12

Adverse fertility effect / decreased fertility / infertility

• (2023): Lavafian A+, Clin Transl Oncol 25(7), 1893-1905 [REVIEW]

Tooth disorder

• (2005): Tredwin CJ+, J Dent Res 84(7), 596-602 [REVIEW]

Toothache (odontalgia)

• (2021): Hino S+, Ann Maxillofac Surg 11(1), 86-90 (6 cases)
• (2010): Zadik Y+, J Endod 36(9), 1588-92